Four recipients presenting with malignant disease other than
bronchogenic carcinoma were excluded from the study. One patient
had a mucosa-associated lymphoid tissue lymphoma in the
explanted lung, one was transplanted for an angiosarcoma, and
two underwent transplantation for metastatic disease limited to
the lung (chondrosarcoma and uterine leiomyoma).